Thyroid patients are being urged to look closely at their pills after a batch of a widely used medication was pulled from shelves nationwide. The Food and Drug Administration has announced a Class II recall of certain lots of levothyroxine sodium tablets distributed by Major Pharmaceuticals, saying the tablets are “subpotent” and may not deliver the full prescribed dose, per Prevention. The drug is commonly used to treat underactive thyroid and goiter, which is an enlarged thyroid gland. The agency says any health effects linked to the lower dose are expected to be temporary and reversible.
The recall covers specific 10-count blister packs and 100-tablet cartons ranging from 25 micrograms to 150mcg, with affected lot numbers listed on the FDA site, and expiration dates stretching from July 2026 to January 2027. Patients are advised to contact their doctor or pharmacist if there’s a match between their meds and the FDA list and to not stop taking the medication unless a medical professional says otherwise.